#USA #Cedar Knolls #Fingerpaint Group #Market Access #Wyatt Gotbetter

Fingerpaint Group Welcomes Wyatt Gotbetter as the New President of Market Access

On September 22, 2026, Fingerpaint Group, an acclaimed healthcare agency recognized in the Med Ad News Network of the Year awards, declared the appointment of Wyatt Gotbetter as its new president of market access. This strategic move aims to bolster Fingerpaint's comprehensive market access capabilities, ensuring that clients receive unparalleled support throughout all stages of product development and commercialization.

Wyatt Gotbetter comes into the role with an impressive background spanning nearly 30 years in various aspects of market access, including payer strategy, health economics, and real-world evidence. As Head of Evidence, Value, and Access at Cytel, his most recent position showcased his expertise in managing complex product commercialization processes. Before that, he was Senior Vice President at Parexel, leading efforts in market access, health economics, outcomes research, and real-world evidence consulting, particularly across novel therapeutic areas like rare diseases and gene therapies.

Bill McEllen, CEO of Fingerpaint Group, emphasized the significance of Gotbetter's diverse experience, stating, "There are very few people in this industry who have worked market access from every angle, covering payer strategy, HEOR, and launch execution, and Wyatt is one of them. His background spans every dimension of market access globally, and he is exactly the right leader to help us go deeper for our clients at every stage of a launch."

Gotbetter's extensive career also included pivotal roles at Biogen, where he oversaw new product commercialization across multiple therapeutic areas such as CNS, oncology, and immunology. Furthermore, he has built payer relations functions at Boston Scientific and held strategy roles at renowned consulting firms like BCG and Health Advances.

In addition to his practical work, Wyatt Gotbetter is highly regarded as a thought leader in the industry, serving as the value and access editor for notable journals like DIA's Global Forum and TIRS. He contributes to academic discussions as a faculty member in BIO's Business Development program and holds degrees in Bachelor of Science and Master of Public Administration from Cornell University. There, he also engages as an adjunct faculty member and executive in residence.

Upon joining Fingerpaint Group, Gotbetter expressed enthusiasm for the agency's unique integrated approach to market access. He noted, "Fingerpaint has built something rare in this industry—a market access capability that brings strategic consulting, creative, and operational execution together under one roof. That integrated approach is exactly what clients need right now, and I am thrilled to be part of it."

About Fingerpaint Group

Fingerpaint Group stands as a top-tier healthcare agency, combining creativity and strategy to lead in the life sciences sector. Partnering with the majority of the top global pharmaceutical giants, the agency focuses on unlocking brand potential through innovative solutions. The organization prides itself on being human-led and AI-enabled, emphasizing the importance of strategic thought over mere automation.

With a remarkable retention rate and a commitment to a science-driven approach, Fingerpaint provides the expertise necessary to navigate the increasingly data-driven landscape of healthcare. To learn more about their services, visit www.fingerpaint.com.

About Knox Lane

Knox Lane, based in San Francisco, is a distinguished investment firm focused on accelerating growth for their partner companies. Their team of experienced investors and operators collaborates to drive transformational growth through a comprehensive approach that includes areas like human capital, brand management, and strategic acquisitions. More details can be found at www.knoxlane.com.